SCHEMBL2299301

SCHEMBL2299301

OC1CN(CN2CCCC2)C1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 2/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
CHRM5 P08912 1/20 0.32
ADRA2C P18825 1/20 0.32
PDK1 Q15118 1/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 2/20 0.32
POLB P06746 1/20 0.32
HPGD P15428 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MAPT P10636 2/20 0.31
ATM Q13315 1/20 0.31
HRH3 Q9Y5N1 2/20 0.31
CYP3A4 P08684 1/20 0.30
CYP2C9 P11712 1/20 0.30
KCNH2 Q12809 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7124323 0.83 ALDH1A1 (0.42) ALDH1A1KDM4ECHRM5ADRA2CTSHR
SCHEMBL7124332 0.83 ALDH1A1 (0.42) ALDH1A1KDM4ECHRM5ADRA2CTSHR
SCHEMBL7578600 0.79 HRH3 (0.39) ALDH1A1KDM4EKMT2AMEN1CHRM5
SCHEMBL2299378 0.78 USP2 (0.41) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL277482 0.76 LMNA (0.47) ALDH1A1KMT2AMEN1CHRM5ADRA2C
SCHEMBL1799442 0.73 HRH3 (0.50) ALDH1A1KDM4EKMT2AMEN1CHRM5
SCHEMBL7007038 0.73 HRH3 (0.50) ALDH1A1KDM4EKMT2AMEN1CHRM5
SCHEMBL348065 0.73 HRH3 (0.50) ALDH1A1KDM4EKMT2AMEN1CHRM5
SCHEMBL3553239 0.73 LMNA (0.44) ALDH1A1KMT2AMEN1CHRM5ADRA2C
SCHEMBL3558131 0.70 HRH3 (0.47) ALDH1A1KDM4EKMT2AMEN1CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999006-B2 Anticancer agents; mitogen-activated protein kinases (MEK) EXELIXIS, INC. (US) 2011-08-16 US claimed